The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic

The coronavirus disease 2019 pandemic has resulted in new challenges for clinicians, head and neck cancer (HNC) patients and carers. There is evidence that the current crisis is affecting the management of HNC patients. Most healthcare systems have introduced remote consultations to decrease the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanatas, Anastasios, Rogers, S. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184241/
https://www.ncbi.nlm.nih.gov/pubmed/32338298
http://dx.doi.org/10.1007/s00405-020-05995-9
_version_ 1783526582768369664
author Kanatas, Anastasios
Rogers, S. N.
author_facet Kanatas, Anastasios
Rogers, S. N.
author_sort Kanatas, Anastasios
collection PubMed
description The coronavirus disease 2019 pandemic has resulted in new challenges for clinicians, head and neck cancer (HNC) patients and carers. There is evidence that the current crisis is affecting the management of HNC patients. Most healthcare systems have introduced remote consultations to decrease the risk of coronavirus infection to patients, carers and clinicians. At present, HNC patients may be anxious and due to logistical issues, may not be adequately prepared for their treatment. To ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 crisis there may be merit in the use of the HaNC-AD PCI.
format Online
Article
Text
id pubmed-7184241
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71842412020-04-27 The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic Kanatas, Anastasios Rogers, S. N. Eur Arch Otorhinolaryngol Short Communication The coronavirus disease 2019 pandemic has resulted in new challenges for clinicians, head and neck cancer (HNC) patients and carers. There is evidence that the current crisis is affecting the management of HNC patients. Most healthcare systems have introduced remote consultations to decrease the risk of coronavirus infection to patients, carers and clinicians. At present, HNC patients may be anxious and due to logistical issues, may not be adequately prepared for their treatment. To ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 crisis there may be merit in the use of the HaNC-AD PCI. Springer Berlin Heidelberg 2020-04-27 2020 /pmc/articles/PMC7184241/ /pubmed/32338298 http://dx.doi.org/10.1007/s00405-020-05995-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Communication
Kanatas, Anastasios
Rogers, S. N.
The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
title The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
title_full The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
title_fullStr The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
title_full_unstemmed The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
title_short The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
title_sort after diagnosis head and neck cancer-specific patient concerns inventory (hanc-ad) as a pre-treatment preparation aid during the covid-19 pandemic
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184241/
https://www.ncbi.nlm.nih.gov/pubmed/32338298
http://dx.doi.org/10.1007/s00405-020-05995-9
work_keys_str_mv AT kanatasanastasios theafterdiagnosisheadandneckcancerspecificpatientconcernsinventoryhancadasapretreatmentpreparationaidduringthecovid19pandemic
AT rogerssn theafterdiagnosisheadandneckcancerspecificpatientconcernsinventoryhancadasapretreatmentpreparationaidduringthecovid19pandemic
AT kanatasanastasios afterdiagnosisheadandneckcancerspecificpatientconcernsinventoryhancadasapretreatmentpreparationaidduringthecovid19pandemic
AT rogerssn afterdiagnosisheadandneckcancerspecificpatientconcernsinventoryhancadasapretreatmentpreparationaidduringthecovid19pandemic

Ejemplares similares